Download PDF

Other users also viewed these articles

Can microvascular damage predict disease severity in patients with systemic sclerosis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Raquel Miriam Ferreira; Miguel Bernardes; Lúcia Costa; Georgina Terroso;
Reumatol Clin. 2024;20:366-71
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters Abeer M. Ghandour; Rania M. Gamal; Gehan Seif Eldein; Aya M. Gamal; Eman El-Hakeim; Marwa A.A. Galal; Fatma H. El-Nouby; Yasmine S. Makarem; Ahmed Abdellatif Awad; Ahmed A. Hafez; Hanan Sayed M. Abozaid;
Reumatol Clin. 2022;18:597-602
Anti-RNA polymerase III antibodies in systemic sclerosis: Multicentric study from Argentina María de los Ángeles Gargiulo; Nicolás Perez; Marina Khoury; Manuel Buhl; Lorena Suárez; Judith Sarano; Fabiana Montoya; Ignacio Bazzalo; Sandra Navarro; Gisela Pendón; María Josefina Molina; Marta Mamani; Mariano Rivero; Graciela Gómez;
Reumatol Clin. 2022;18:368-73